NS
ATOS icon

NBC Securities’s Atossa Therapeutics ATOS Stock Holding History

NBC Securities’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$88 – 2571
2025
Q4 		$88 Hold
10
– – ﹤0.01% 2748
2025
Q3 		$130 Buy
+10
New +$124 ﹤0.01% 2735
2024
Q2 		– Sell
-10
Closed -$1K – 2084
2024
Q1 		$1K Buy
+10
New +$161 ﹤0.01% 2036
2023
Q4 		– Sell
-10
Closed – – 2116
2023
Q3 		$0 Buy
+10
New +$145 ﹤0.01% 2111

Other funds holding ATOS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NBC Securities's ATOS Position: Q1 2026 in Review

NBC Securities sold out of Atossa Therapeutics (ATOS) in Q1 2026, closing a stake of 10 shares — an estimated $88 sold.

NBC Securities first reported a position in ATOS in Q3 2023 and held it in 4 quarters. The position peaked at $1K in Q1 2024. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.

  • NBC Securities reported no remaining Atossa Therapeutics position as of Q1 2026 after selling out during the quarter.
  • NBC Securities sold 10 Atossa Therapeutics shares in Q1 2026, an estimated $88.
  • NBC Securities first reported a position in Atossa Therapeutics in Q3 2023 and held it in 4 quarters.
  • NBC Securities's Atossa Therapeutics position peaked at $1K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.